The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Defective CD8 T Cell Memory Following Acute Infection Without CD4 T Cell Help
Open accessAbstract
The CD8 + cytotoxic T cell response to pathogens is thought to be CD4 + helper T cell independent because infectious agents provide their own inflammatory signals. Mice that lack CD4 + T cells mount a primary CD8 response to Listeria monocytogenes equal to that of wild-type mice and rapidly clear the infection. However, protective memory to a challenge is gradually lost in the former animals. Memory CD8 + T cells from normal mice can respond rapidly, but memory CD8 + T cells that are generated without CD4 help are defective in their ability to respond to secondary encounters with antigen. The results highlight a previously undescribed role for CD4 help in promoting protective CD8 memory development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Without this additional signal, the activated ‘helpless’ CTL function as primary effector T cells but with a short lifespan69 or die via activation-induced cell death following subsequent exposure to antigen70,71.”
From Immunogenic and tolerogenic cell death (2009) · cites this paper as [70]
In the citing paper
“The latter cell death is mediated by expression of the death ligand TRAIL, which triggers apoptosis in the helpless CTL as well as other activated T cells70,72.”
From Immunogenic and tolerogenic cell death (2009) · cites this paper as [70]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Janeway, C. A., & Medzhitov, R. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.083001.084359 · Cited by 8,394
T-cell help for cytotoxic T lymphocytes is mediated by CD40–CD40L interactions
Schoenberger, S. P., Toes, R. E. M., van der Voort, E. I. H., Offringa, R., & Melief, C. J. M. (1998) · Nature · doi:10.1038/31002 · Cited by 2,615
A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell
Ridge, J. P., Rosa, F. D., & Matzinger, P. (1998) · Nature · doi:10.1038/30989 · Cited by 2,360
Help for cytotoxic-T-cell responses is mediated by CD40 signalling
Bennett, S. R. M., Carbone, F., Karamalis, F., Flavell, R. A., Miller, J. F. A. P., & Heath, W. R. (1998) · Nature · doi:10.1038/30996 · Cited by 2,091
Viral Immune Evasion Due to Persistence of Activated T Cells Without Effector Function
Zajac, A. J., Blattman, J. N., Murali-Krishna, K., Sourdive, D. J. D., Suresh, M., Altman, J. D., & Ahmed, R. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2205 · Cited by 1,978
CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes
Janssen, E. M., Lemmens, E. E., Wolfe, T., Christen, U., von Herrath, M. G., & Schoenberger, S. P. (2003) · Nature · doi:10.1038/nature01441 · Cited by 1,635
CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection
Matloubian, M., Concepcion, R. J., & Ahmed, R. (1994) · Journal of Virology · doi:10.1128/jvi.68.12.8056-8063.1994 · Cited by 1,162
Gordon, S. (2002) · Cell · doi:10.1016/s0092-8674(02)01201-1 · Cited by 1,153
Rahemtulla, A., Fung‐Leung, W., Schilham, M. W., Kündig, T. M., Sambhara, S. R., Narendran, A., Arabian, A., Wakeham, A. C., Paige, C. J., Zinkernagel, R. M., et al. (1991) · Nature · doi:10.1038/353180a0 · Cited by 685
The Critical Need for CD4 Help in Maintaining Effective Cytotoxic T Lymphocyte Responses
Kalams, S. A., & Walker, B. D. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2199 · Cited by 660
Cited by
Sorted by citations
Items 401–500 of 999
Romagnoli, P. A., Fu, H., Qiu, Z., Khairallah, C. F., Pham, Q. M., Puddington, L., Khanna, K. M., Lefrançois, L., & Sheridan, B. S. (2016) · Mucosal Immunology · doi:10.1038/mi.2016.66 · Cited by 58
T cell memory and protective immunity by vaccination: is more better?
Zanetti, M., & Franchini, G. (2006) · Trends in Immunology · doi:10.1016/j.it.2006.09.004 · Cited by 55
CD8+ T-cell memory: only the good ones last
Northrop, J. K., & Shen, H. (2004) · Current Opinion in Immunology · doi:10.1016/j.coi.2004.05.004 · Cited by 56
Singh, S., Streng‐Ouwehand, I., Litjens, M., Kalay, H., Burgdorf, S., Saeland, E., Kurts, C., Unger, W. W. J., & van Kooyk, Y. (2011) · European Journal of Immunology · doi:10.1002/eji.201040762 · Cited by 55
Immune outcomes in the liver: Is CD8 T cell fate determined by the environment?
Wong, Y. C., Tay, S. S., McCaughan, G. W., Bowen, D. G., & Bertolino, P. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.05.033 · Cited by 58
Sarvestani, S. T., & McAuley, J. (2017) · Antiviral Research · doi:10.1016/j.antiviral.2017.10.020 · Cited by 55
Lacap, P. A., Huntington, J. D., Luo, M., Nagelkerke, N. J. D., Bielawny, T., Kimani, J., Wachihi, C., NGUGI, E. N., & Plummer, F. A. (2008) · AIDS · doi:10.1097/qad.0b013e3282ffb3db · Cited by 55
Zheng, N. N., Kiviat, N. B., Sow, P. S., Hawes, S. E., Wilson, A. J., Agne, H. D., Critchlow, C. W., Gottlieb, G. S., Musey, L. K., & McElrath, M. J. (2004) · Journal of Virology · doi:10.1128/jvi.78.24.13934-13942.2004 · Cited by 55
Genetic approaches for the induction of a CD4+ T cell response in cancer immunotherapy
Bonehill, A., Heirman, C., & Thielemans, K. (2005) · The Journal of Gene Medicine · doi:10.1002/jgm.713 · Cited by 55
Improving T cell responses to modified peptides in tumor vaccines
Buhrman, J. D., & Slansky, J. E. (2012) · Immunologic Research · doi:10.1007/s12026-012-8348-9 · Cited by 54
Ectopic Expression of Epidermal Antigens Renders the Lung a Target Organ in Paraneoplastic Pemphigus
Hata, T., Nishimoto, S., Nagao, K., Takahashi, H., Yoshida, K., Ohyama, M., Yamada, T., Asano, K., & Amagai, M. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203536 · Cited by 54
Stockenhuber, K., Hegazy, A. N., West, N. R., Ilott, N. E., Stockenhuber, A., Bullers, S. J., Thornton, E. E., Arnold, I. C., Tucci, A., Waldmann, H., et al. (2018) · The Journal of Experimental Medicine · doi:10.1084/jem.20172094 · Cited by 54
Pearce, E. L., Shedlock, D. J., & Shen, H. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.4.2494 · Cited by 54
Development of effective immunotherapy for the treatment of patients with cancer
Rosenberg, S. A. (2004) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2004.01.025 · Cited by 55
Speiser, D. E., Pittet, M. J., Rimoldi, D., Guillaume, P., Luescher, I. F., Líénard, D., Lejeune, F. J., Cerottini, J., & Romero, P. J. (2003) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2003.09.010 · Cited by 54
Deficiency of HIV-Gag-Specific T Cells in Early Childhood Correlates with Poor Viral Containment
Huang, S., Dunkley-Thompson, J., Tang, Y., Macklin, E. A., Steel-Duncan, J., Singh-Minott, I., Ryland, E. G., Smikle, M., Walker, B. D., Christie, C. D. C., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.11.8103 · Cited by 54
Carollo, M., Palazzo, R., Bianco, M., Pandolfi, E., Chionne, P., Fedele, G., Tozzi, A. E., Carsetti, R., Romanò, L., & Ausiello, C. M. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.11.029 · Cited by 53
Palucka, K., Ueno, H., Roberts, L. K., Fay, J. W., & Banchereau, J. (2010) · The Cancer Journal · doi:10.1097/ppo.0b013e3181eaca83 · Cited by 54
T‐cell help permits memory CD8+ T‐cell inflation during cytomegalovirus latency
Walton, S. M., Torti, N., Mandarić, S., & Oxenius, A. (2011) · European Journal of Immunology · doi:10.1002/eji.201141575 · Cited by 51
Differences in maintenance of CD8+ and CD4+ bacteria‐specific effector‐memory T cell populations
Schiemann, M., Busch, V., Linkemann, K., Huster, K. M., & Busch, D. H. (2003) · European Journal of Immunology · doi:10.1002/eji.200324224 · Cited by 51
Sant, A. J., Chaves, F. A., Krafcik, F. R., Lazarski, C. A., Menges, P. R., Richards, K. A., & Weaver, J. M. (2007) · Expert Review of Vaccines · doi:10.1586/14760584.6.3.357 · Cited by 52
Schieffer, M., Jessen, H. K., Oster, A. F., Pissani, F., Soghoian, D. Z., Lu, R., Jessen, A. B., Zedlack, C., Schultz, B. T., Davis, I., et al. (2014) · Journal of Virology · doi:10.1128/jvi.00728-14 · Cited by 52
BenMarzouk‐Hidalgo, O. J., Cisneros, J. M., Cordero, E., Martín‐Peña, A., Sánchez, B., Martín‐Gandul, C., Gentil, M. A., Gómez‐Bravo, M. Á., Lage, E., & Pérez‐Romero, P. (2011) · Transplantation · doi:10.1097/tp.0b013e3182115ba2 · Cited by 53
AFP-specific CD4+ Helper T-cell Responses in Healthy Donors and HCC Patients
Evdokimova, V. N., Liu, Y., Potter, D. M., & Butterfield, L. H. (2007) · Journal of Immunotherapy · doi:10.1097/cji.0b013e31802fd8e2 · Cited by 52
Orr, M. T., Orgun, N. N., Wilson, C. B., & Way, S. S. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.8.4731 · Cited by 52
Rocha, B., & Tanchot, C. (2004) · Seminars in Immunology · doi:10.1016/j.smim.2004.08.011 · Cited by 52
Molecular adjuvant HMGB1 enhances anti-influenza immunity during DNA vaccination
Fagone, P., Shedlock, D. J., Bao, H., Kawalekar, O. U., Yan, J., Gupta, D., Morrow, M. P., Patel, A. R., Kobinger, G. P., Muthumani, K., et al. (2011) · Gene Therapy · doi:10.1038/gt.2011.59 · Cited by 51
Quick to remember, slow to forget: rapid recall responses of memory CD8+ T cells
DiSpirito, J. R., & Shen, H. (2009) · Cell Research · doi:10.1038/cr.2009.140 · Cited by 51
Nchinda, G., Amadu, D., Trumpfheller, C., Mizenina, O. A., Überla, K., & Steinman, R. M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000621107 · Cited by 52
Lipid-containing mimetics of natural triggers of innate immunity as CTL-inducing influenza vaccines
Lau, Y. F., Deliyannis, G., Zeng, W., Mansell, A. S., Jackson, D. C., & Brown, L. E. (2006) · International Immunology · doi:10.1093/intimm/dxl114 · Cited by 51
Dullaers, M., & Thielemans, K. (2005) · The Journal of Gene Medicine · doi:10.1002/jgm.846 · Cited by 52
Garber, D. A., Silvestri, G., Barry, A. P., Fedanov, A., Kozyr, N. L., McClure, H. M., Montefiori, D. C., Larsen, C. P., Altman, J. D., Staprans, S. I., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19442 · Cited by 51
The Multifaceted Role of Th17 Lymphocytes and Their Associated Cytokines in Cancer
Alizadeh, D., Katsanis, E., & Larmonier, N. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/957878 · Cited by 55
HER-2/neu as a Target for Cancer Vaccines
Baxevanis, C. N., Voutsas, I. F., Gritzapis, A. D., Perez, S. A., & Papamichail, M. (2010) · Immunotherapy · doi:10.2217/imt.09.89 · Cited by 49
Rajasagi, N. K., Kassim, S. H., Kollias, C. M., Zhao, X., Chervenak, R., & Jennings, S. R. (2009) · Journal of Virology · doi:10.1128/jvi.01997-08 · Cited by 52
Fernandez‐Ruiz, D., Lau, L. S., Ghazanfari, N., Jones, C. M., Ng, W. Y., Davey, G. M., Berthold, D. L., Holz, L. E., Kato, Y., Enders, M. H., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700186 · Cited by 48
Orgun, N. N., Mathis, M. A., Wilson, C. B., & Way, S. S. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.6.4109 · Cited by 50
Type I interferons promote cross-priming: more functions for old cytokines
Beignon, A., Škoberne, M., & Bhardwaj, N. (2003) · Nature Immunology · doi:10.1038/ni1003-939 · Cited by 50
Mooij, P., Nieuwenhuis, I. G., Knoop, C. J., Doms, R. W., Bogers, W. M. J. M., ten Haaft, P., Niphuis, H., Koornstra, W., Bieler, K., Köstler, J., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.7.3333-3342.2004 · Cited by 50
Putative Role of Vitamin D for COVID-19 Vaccination
Chiu, S.-K., Tsai, K., Wu, C., Zheng, C., Yang, C., Hu, W., Hou, Y., Lu, K., & Chao, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168988 · Cited by 50
Reactive oxygen species associated immunoregulation post influenza virus infection
Wang, L., Cao, Z., Wang, Z., Guo, J., & Wen, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.927593 · Cited by 50
IL‐4‐mediated fine tuning of IL‐12p70 production by human DC
Guenova, E., Volz, T., Sauer, K., Kaesler, S., Müller, M., Wölbing, F., Chen, K.-M., Schwärzler, C., Brossart, P., Röcken, M., et al. (2008) · European Journal of Immunology · doi:10.1002/eji.200838463 · Cited by 48
Early events regulating immunity and pathogenesis during Listeria monocytogenes infection
Williams, M. A., Schmidt, R. L., & Lenz, L. L. (2012) · Trends in Immunology · doi:10.1016/j.it.2012.04.007 · Cited by 47
Postthymic maturation influences the CD8 T cell response to antigen
Makaroff, L., Hendricks, D. W., Niec, R. E., & Fink, P. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812354106 · Cited by 50
Assudani, D., Cho, H.-I., DeVito, N. C., Bradley, N., & Celis, E. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-3134 · Cited by 48
Stagno, S., & Britt, W. J. (2006) · Elsevier eBooks · doi:10.1016/b0-72-160537-0/50025-6 · Cited by 49
Immunological Foundations to the Quest for New Vaccine Adjuvants
Burdin, N., Guy, B., & Moingeon, P. E. (2004) · BioDrugs · doi:10.2165/00063030-200418020-00002 · Cited by 49
CD8 T Cells Mediate Transient Herpes Stromal Keratitis in CD4-Deficient Mice
Lepisto, A. J., Frank, G. M., Xu, M. J., Stuart, P. M., & Hendricks, R. L. (2006) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.05-0898 · Cited by 49
Impaired Memory CD8 T Cell Development in the Absence of Methyl-CpG-Binding Domain Protein 2
Kersh, E. N. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.6.3821 · Cited by 49
Cell-Associated Double-Stranded RNA Enhances Antitumor Activity through the Production of Type I IFN
McBride, S. W., Hoebe, K. H. N., Georgel, P., & Janssen, E. M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.9.6122 · Cited by 50
Enhancement of HIV-Specific CD8 T Cell Responses by Dual Costimulation with CD80 and CD137L
Bukczynski, J., Wen, T., Wang, C., Christie, N., Routy, J., Boulassel, M., Kovacs, C. M., MacDonald, K. S., Ostrowski, M., Sékaly, R., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.10.6378 · Cited by 49
Memory CD4 T cells enhance primary CD8 T-cell responses
Krawczyk, C. M., Shen, H., & Pearce, E. J. (2007) · Infection and Immunity · doi:10.1128/iai.00086-07 · Cited by 48
T Cell Memory in Infection, Cancer, and Autoimmunity
Barnaba, V. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.811968 · Cited by 49
Intrinsic and extrinsic control of effector T cell survival and memory T cell development
Hand, T. W., & Kaech, S. M. (2008) · Immunologic Research · doi:10.1007/s12026-008-8027-z · Cited by 49
CHOWDHARY, V. R., Tilahun, A. Y., Clark, C. R., Grande, J. P., & Rajagopalan, G. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201097 · Cited by 47
Jülg, B. D., Moodley, E. S., Qi, Y., Ramduth, D., Reddy, S., Mncube, Z., Gao, X., Goulder, P., Detels, R., Ndung’u, T., et al. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiq122 · Cited by 47
The effect of aging on cognate function and development of immune memory
Haynes, L. (2005) · Current Opinion in Immunology · doi:10.1016/j.coi.2005.07.003 · Cited by 49
Stockinger, B., Kassiotis, G., & Bourgeois, C. (2004) · Seminars in Immunology · doi:10.1016/j.smim.2004.08.010 · Cited by 48
Yamamoto, T., Iwamoto, N., Yamamoto, H., Tsukamoto, T., Kuwano, T., Takeda, A., Kawada, M., Tsunetsugu‐Yokota, Y., & Matano, T. (2009) · Journal of Virology · doi:10.1128/jvi.00145-09 · Cited by 48
A Novel Role of CD30/CD30 Ligand Signaling in the Generation of Long-Lived Memory CD8+ T Cells
Nishimura, H., Yajima, T., Muta, H., Podack, E. R., Tani, K., & Yoshikai, Y. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.7.4627 · Cited by 46
Bachmann, M. F., Schwarz, K., Wolint, P., Meijerink, E., Martin, S. W., Manolova, V., & Oxenius, A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.4.2217 · Cited by 48
DNA-based vaccines activate innate and adaptive antitumor immunity by engaging the NKG2D receptor
Zhou, H., Luo, Y., Lo, J., Kaplan, C. D., Mizutani, M., Mizutani, N., Lee, J.-D., Primus, F. J., Becker, J. C., Xiang, R., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502208102 · Cited by 48
Qiu, Z., Khairallah, C. F., & Sheridan, B. S. (2018) · Pathogens · doi:10.3390/pathogens7020055 · Cited by 53
Abdellrazeq, G. S., Fry, L. M., Elnaggar, M. M., Bannantine, J. P., Schneider, D. A., Chamberlin, W., Mahmoud, A. H., Park, K. T., Hulubei, V., & Davis, W. C. (2020) · Vaccine · doi:10.1016/j.vaccine.2019.12.052 · Cited by 48
Memory CD8+ T Cells Protect Dendritic Cells from CTL Killing
Watchmaker, P. B., Urban, J. A., Berk, E., Nakamura, Y., Mailliard, R. B., Watkins, S. C., van Ham, S. M., & Kaliński, P. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.6.3857 · Cited by 44
Cao, T., Ueno, H., Glaser, C., Fay, J. W., Palucka, K., & Banchereau, J. (2007) · European Journal of Immunology · doi:10.1002/eji.200636499 · Cited by 51
Delayed Clearance ofEhrlichia chaffeensisInfection in CD4+T-Cell Knockout Mice†
Ganta, R. R., Cheng, C., Wilkerson, M. J., & Chapes, S. K. (2003) · Infection and Immunity · doi:10.1128/iai.72.1.159-167.2004 · Cited by 47
Lütjen, S., Soltek, S., Virna, S., Deckert, M., & Schlüter, D. (2006) · Infection and Immunity · doi:10.1128/iai.00098-06 · Cited by 48
Westwood, J. A., Kelly, J. M., Tanner, J. E., Kershaw, M. H., Smyth, M. J., & Hayakawa, Y. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.2.757 · Cited by 47
The Roles of CD4+T Cells in Tumor Immunity
Lai, Y., Jeng, C., & Chen, S.-C. (2011) · ISRN Immunology · doi:10.5402/2011/497397 · Cited by 47
Manipulating immune cells for adoptive immunotherapy of cancer
Darcy, P. K., Neeson, P. J., Yong, C. S. M., & Kershaw, M. H. (2014) · Current Opinion in Immunology · doi:10.1016/j.coi.2014.01.008 · Cited by 50
Ballesteros‐Tato, A., León, B., Lund, F. E., & Randall, T. D. (2013) · The Journal of Experimental Medicine · doi:10.1084/jem.20130097 · Cited by 46
Eppert, B. L., Wortham, B. W., Flury, J. L., & Borchers, M. T. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1202442 · Cited by 46
Dong, H., Franklin, N. A., Roberts, D. J., Yagita∥, H., Glennie, M. J., & Bullock, T. N. J. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103329 · Cited by 46
Kobori, H., Hashiguchi, M., Piao, J., Kato, M., Ritprajak, P., & Azuma, M. (2010) · Immunology · doi:10.1111/j.1365-2567.2009.03236.x · Cited by 46
Primary CD8 + T-Cell Response to Soluble Ovalbumin Is Improved by Chloroquine Treatment In Vivo
Garulli, B., Stillitano, M. G., Barnaba, V., & Castrucci, M. R. (2008) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00166-08 · Cited by 46
Beatty, G. L., Smith, J. S., Reshef, R., Patel, K. P., Colligon, T. A., Vance, B. A., Frey, N. V., Johnson, F. B., Porter, D. L., & Vonderheide, R. H. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-3332 · Cited by 45
CD8+ T Cell-Mediated Airway Hyperresponsiveness and Inflammation Is Dependent on CD4+IL-4+ T Cells
Koya, T., Miyahara, N., Takeda, K., Matsubara, S., Matsuda, H., Swasey, C. H., Balhorn, A., Dakhama, A., & Gelfand, E. W. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.5.2787 · Cited by 46
Hong, L., Alu, A., Yang, J., Ren, W., He, C., Lan, T., He, X., Yang, L., Li, J., Wang, Z., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01002-1 · Cited by 43
Kornberg, A. E., Botella, T., Moon, C. S., Rao, S., Gelbs, J., Cheng, L., Miller, J. D., Baccarella, A., Garcia‐Vilas, J. A., Vargas, J., et al. (2023) · Science Immunology · doi:10.1126/sciimmunol.adf4312 · Cited by 45
Hoyer, S., Prommersberger, S., Pfeiffer, I. A., Schuler‐Thurner, B., Schuler, G., Dörrie, J., & Schaft, N. (2014) · European Journal of Immunology · doi:10.1002/eji.201444477 · Cited by 45
Cancer vaccines for established cancer: how to make them better?
Andrews, D. M., Maraskovsky, E., & Smyth, M. J. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00612.x · Cited by 46
Antigen Persistence Is Required for Dendritic Cell Licensing and CD8+ T Cell Cross-Priming
Jusforgues-Saklani, H., Uhl, M., Blachère, N. E., Lemaı̂tre, F., Lantz, O. J., Bousso, P., Braun, D., Moon, J. J., & Albert, M. L. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.5.3067 · Cited by 47
Padilla, A. M., Xu, D., Martin, D. L., & Tarleton, R. L. (2006) · Infection and Immunity · doi:10.1128/iai.01245-06 · Cited by 43
Turner, M. S., Cohen, P., & Finn, O. J. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.5.2787 · Cited by 43
Stambas, J., Guillonneau, C., Kedzierska, K., Mintern, J. D., Doherty, P. C., & Gruta, N. L. L. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.08.007 · Cited by 43
Sanchez-Perez, L. A., Kottke, T. J., Daniels, G. A., Díaz, R. M., Thompson, J., Pulido, J. S., Melcher, A. A., & Vile, R. G. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.6.4168 · Cited by 44
LaCelle, M. G., Jensen, S. M., & Fox, B. A. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1113 · Cited by 43
Recent Advances In Developing Synthetic Carbohydrate-Based Vaccines For Cancer Immunotherapies
Hevey, R., & Ling, C. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.11.193 · Cited by 43
Committed to memory: lineage choices for activated T cells
Moulton, V. R., & Färber, D. L. (2006) · Trends in Immunology · doi:10.1016/j.it.2006.04.006 · Cited by 43
Lawrence, B. P. (2004) · Toxicological Sciences · doi:10.1093/toxsci/kfh094 · Cited by 44
Exploiting the Redundancy in the Immune System
Casadevall, A., & Pirofski, L. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030637 · Cited by 44
Jones, N. D., Carvalho‐Gaspar, M., Luo, S., Brook, M. O., Martin, L., & Wood, K. J. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.4.2316 · Cited by 44
Gil, L., López, C., Blanco, A., Lazo, L., Martin, J. H., Valdés, I., Romero, Y., Figueroa, Y., Guillén, G. E., & Hermida, L. (2009) · Viral Immunology · doi:10.1089/vim.2008.0063 · Cited by 42
Th Cells Act Via Two Synergistic Pathways To Promote Antiviral CD8+ T Cell Responses
Wiesel, M., Joller, N., Ehlert, A.-K., Crouse, J., Spörri, R., Bachmann, M. F., & Oxenius, A. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001990 · Cited by 42
Castiglioni, P., Gerloni, M., & Zanetti, M. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.06.028 · Cited by 42
HIV-1 transgenic rats develop T cell abnormalities
Reid, W. C., Abdelwahab, S. F., Sadowska, M., Huso, D. L., Neal, A. E., Ahearn, A., Bryant, J., Gallo, R. C., Lewis, G. K., & Reitz, M. S. (2004) · Virology · doi:10.1016/j.virol.2003.12.010 · Cited by 43
Ciavarra, R. P., Taylor, L., Greene, A. R., Yousefieh, N., Horeth, D. R., van Rooijen, N., Steel, C., Gregory, B. W., Birkenbach, M. P., & Sekellick, M. J. (2005) · Virology · doi:10.1016/j.virol.2005.07.031 · Cited by 43
T cell–mediated suppression of angiogenesis results in tumor protective immunity
Zhou, H., Luo, Y., Mizutani, M., Mizutani, N., Reisfeld, R. A., & Xiang, R. (2005) · Blood · doi:10.1182/blood-2005-03-0969 · Cited by 43
van Bockel, D. J., Price, D. A., Munier, C. M. L., Venturi, V., Asher, T. E., Ladell, K., Greenaway, H. Y., Zaunders, J., Douek, D. C., Cooper, D. A., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001807 · Cited by 43
Metadata
- Authors
- Sun, J. C., & Bevan, M. J.
- Affiliations
- Howard Hughes Medical Institute (US)
- Corresponding author
- Bevan, Michael J.
- Venue
- Science
- Published
- 2003-04-11
- Volume
- 300
- Issue
- 5617
- Pages
- 339-342
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC2778341
- OpenAlex
- W2076534074
- Cited by
- 1,213
- References
- 26
- Citations by year
- 2026: 4 · 2025: 16 · 2024: 18 · 2023: 18 · 2022: 19 · 2021: 31 · 2020: 28 · 2019: 18 · 2018: 24 · 2017: 21 · 2016: 28 · 2015: 32 · 2014: 51 · 2013: 46 · 2012: 58
- FWCI
- 40.97
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institute of Allergy and Infectious Diseases (R01AI019335, AI-19335)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
- Keywords
- CD8+ T cell memory, CD4+ T cell help, Listeria monocytogenes, acute infection, CD4-deficient mice, cytotoxic T lymphocytes, protective immunity
- MeSH terms
- Animals, Cytotoxicity, Immunologic, Genes, MHC Class II, T-Lymphocytes, Helper-Inducer, Immunization, Immunologic Memory, Interferon-gamma, Listeriosis, Listeria monocytogenes, Mice, Inbred C57BL, Ovalbumin, T-Lymphocyte Subsets, CD8-Positive T-Lymphocytes, Adoptive Transfer, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review